Quality of life (QOL) with sunitinib versus interferon-alfa (IFN-α) as first-line therapy in patients with metastatic renal cell carcinoma (mRCC): Final results Meeting Abstract
| Authors: | Cella, D.; Michaelson, M. D.; Cappelleri, J. C.; Bushmakin, A. G.; Charbonneau, C.; Kim, S. T.; Li, J. Z.; Motzer, R. J. |
| Abstract Title: | Quality of life (QOL) with sunitinib versus interferon-alfa (IFN-α) as first-line therapy in patients with metastatic renal cell carcinoma (mRCC): Final results |
| Meeting Title: | 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 27 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2009 May 29-Jun 2 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2009-05-20 |
| Start Page: | 330s |
| Language: | English |
| ACCESSION: | WOS:000276606604378 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2009.27.15_suppl.6529 |
| Notes: | Meeting Abstract: 6529 -- Source: Wos |
